论文部分内容阅读
作者对127例进行性肺癌放射治疗成绩进行了研究,年龄平均60.4岁,男女之比为3.5:1。按UICC分期,Ⅳ期最多,占72％(91/127),Ⅲ期占25％(32/127),以鳞癌最多,其次为腺癌,小细胞癌及大细胞癌。115例作了7个月追踪观察,其中原发灶放疗88例,转移灶治疗27例。原发灶放疗中,原始接受放疗为A组,共47例,经各种化疗后再作放疗者为B组,共17例,放疗+手术14例,再发治疗10例。放疗的原则是前后对穿二野法照射,Ⅲ、Ⅳ期肺癌大部分病例均照射原发灶和纵隔淋巴结,剂量为10Gy/5次/周,A、B组总剂量,
The authors studied the results of 127 cases of progressive lung cancer radiotherapy, with an average age of 60.4 years and a ratio of 3.5 to 1. According to UICC staging, stage IV was the most common, accounted for 72% (91/127), and stage III accounted for 25% (32/127). Most squamous cell carcinomas were followed, followed by adenocarcinoma, small cell carcinoma, and large cell carcinoma. 115 cases were followed up for 7 months, including 88 cases of primary tumor radiotherapy and 27 cases of metastatic tumor. In the primary radiotherapy, the original radiotherapy received group A, a total of 47 cases, after a variety of chemotherapy after radiotherapy for the B group, a total of 17 cases, radiotherapy + surgery in 14 cases, 10 cases of recurrent treatment. The principle of radiotherapy is to irradiate the field before and after irradiation. Most cases of stage III and IV lung cancer are irradiated with primary tumors and mediastinal lymph nodes at a dose of 10 Gy/5 times/week. The total doses of groups A and B are